Related Experiment Video
Updated: Oct 8, 2026

Fertility Preservation in Patients with Severe Ovarian Dysfunction
Published on: March 25, 2021
Treatment of Vogt-Koyanagi- Harada's disease during pregnancy
N Miyata1, M Sugita, S Nakamura
1Department of Ophthalmology, Yokohama City University School of Medicine, Yokahama, Japan.
Background:
Caution should be exercised in treating patients with autoimmune diseases during pregnancy.
Cases:
We successfully treated three cases of Vogt-Koyanagi-Harada's disease (VKH disease) during pregnancy.
Observations:
In the second trimester (14-27 weeks) of 1 patient, inflammation was mild and could be treated by topical corticosteroid. There is the possibility that her immune response had been modified by pregnancy. Systemic corticosteroid in a high dose was administered to the two cases in the second and third trimesters of pregnancy (28-41 weeks). The severity of inflammation in these 2 patients was similar to that in nonpregnant women. Inflammation subsided immediately without recurrence in all cases. No abnormality was found during the deliveries or in the babies.
Conclusions:
Treatment for VKH disease during pregnancy should be chosen according to the severity of inflammation, the stage of pregnancy, and the maternal and fetal conditions.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Mitral Stenosis III: Medical Management
Angle Closure Glaucoma: Treatment
Rheumatic Heart Disease III: Medical Management
Graves' Disease I: Introduction
Mitral Regurgitation III: Medical Management

